Springer Targets of Treatment in Chronic Inflammatory Bowel Diseases

Explore the evolving landscape of gastroenterology with Targets of Treatment in Chronic Inflammatory Bowel Diseases: 131. This specialized volume from the Falk Symposium series provides a deep look into the progress made in understanding the pathophysiology of inflammatory bowel disease. Following the identification of the first gene responsible for Crohn's disease, medical research has advanced significantly, making it vital to examine therapeutic targets within a broader context. This publication captures the insights from the Falk Symposium No. 131, held in Freiburg, Germany, during the Gastroenterology Week in October 2002. The content focuses on newly defined and alternative therapeutic targets, offering a unique perspective by incorporating knowledge from experts across various scientific fields. It serves as a valuable resource for medical professionals and researchers looking to understand the historical and scientific foundations of modern IBD treatment strategies.